Actuate Therapeutics ACTU
NASDAQ ACTU
$0.71 +0.02 (+3.47%)
As of: Sep 30, 2026 · 10:23 AM EDT

Actuate Therapeutics (ACTU) EPS (Basic) (2023 - 2026)

Updated

Actuate Therapeutics (ACTU) posted EPS (Basic) of -$0.20 for Q2 2026, compared with -$0.30 a year earlier.

Analysis

Actuate Therapeutics (ACTU) EPS (Basic) (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EPS (Basic) at Actuate Therapeutics was -$0.87; for FY2025, it came in at -$1.06.

  • In prior years, Actuate Therapeutics' EPS (Basic) was -$3.26 in FY2024 and -$17.24 in FY2023.
  • The Q2 2026 figure stands as the highest quarterly EPS (Basic) in data going back to Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 2.30
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.04
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -0.54
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 1.68
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 1.87
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.40
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -8.44
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 4.34
10 Actuate Therapeutics 17.77 Mn 17.77 Mn - -0.20
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.20
Dec 31, 2025 -0.22
Sep 30, 2025 -0.25
Jun 30, 2025 -0.30
Mar 31, 2025 -0.32
Dec 31, 2024 -0.77
Sep 30, 2024 -0.55
Jun 30, 2024 -4.20
Mar 31, 2024 -5.40
Dec 31, 2023 -5.30
Sep 30, 2023 -4.31
Jun 30, 2023 -3.88
API Access

Actuate Therapeutics EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=ACTU&period=max&api_key=YOUR_API_KEY